-+ 0.00%
-+ 0.00%
-+ 0.00%

Intelligent Bio Solutions starts validation study for sub-3-minute drug screening cartridge

PUBT·04/20/2026 22:04:09
Listen to the news
Intelligent Bio Solutions starts validation study for sub-3-minute drug screening cartridge
  • Intelligent Bio Solutions launched a validation study to cut analysis time for its Intelligent Fingerprinting Drug Screening System to under 3 minutes from about 10 minutes.
  • Program targets a roughly 70% faster time-to-result to support planned entry into global roadside drug testing.
  • Company cited U.S. roadside drug testing market size of $1.17 billion in 2023 with projection of $1.62 billion by 2030.
  • INBS flagged ongoing work toward FDA 510(k) clearance for codeine detection to expand use beyond current Forensic Use Only deployment in U.S.
  • Validation study remains in preliminary phase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.